FLGT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fulgent Genetics Inc

Watchlist Manager

Watchlist

Price: 21.55 USD 1.32% Market Closed

Market Cap: $612m

	Fulgent Genetics Inc NASDAQ:FLGT	US
M	Mycenax Biotech Inc TPEX:4726	TW
	Subsea 7 SA OSE:SUBC	UK

Profitability Summary

Fulgent Genetics Inc's profitability score is 18/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

36%

Sustainable 3Y Average Gross Margin

38%

Gross Margin is Increasing

32% > 36%

Negative Operating Margin

-37%

Negative 3Y Average Operating Margin

-35%

Declining Operating Margin

-26% > -37%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-16% > -26%

Negative Free Cash Flow Margin

-32%

Negative 3Y Average Free Cash Flow Margin

-12%

Declining Free Cash Flow Margin

10% > -32%

Negative ROE

-8%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-11%

Declining ROIC

-7% > -13%

View All

Hide

Collapse

18 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.